Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,395 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predicting the efficacy of first-line immunotherapy by combining cancer cachexia and tumor burden in advanced non-small cell lung cancer.
Miyawaki T, Naito T, Doshita K, Kodama H, Mori M, Nishioka N, Iida Y, Miyawaki E, Mamesaya N, Kobayashi H, Omori S, Ko R, Wakuda K, Ono A, Kenmotsu H, Murakami H, Mori K, Harada H, Endo M, Takahashi K, Takahashi T. Miyawaki T, et al. Among authors: mori k, mori m. Thorac Cancer. 2022 Jul;13(14):2064-2074. doi: 10.1111/1759-7714.14529. Epub 2022 Jun 13. Thorac Cancer. 2022. PMID: 35698259 Free PMC article. Review.
Comparison of chemotherapeutic efficacy between LCNEC diagnosed using large specimens and possible LCNEC diagnosed using small biopsy specimens.
Tokito T, Kenmotsu H, Watanabe R, Ito I, Shukuya T, Ono A, Nakamura Y, Tsuya A, Naito T, Murakami H, Takahashi T, Ohde Y, Kondo H, Endo M, Kameya T, Nakajima T, Mori K, Yamamoto N. Tokito T, et al. Among authors: mori k. Int J Clin Oncol. 2014 Feb;19(1):63-7. doi: 10.1007/s10147-012-0509-2. Epub 2012 Dec 19. Int J Clin Oncol. 2014. PMID: 23250620
Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system.
Hosokawa M, Kenmotsu H, Koh Y, Yoshino T, Yoshikawa T, Naito T, Takahashi T, Murakami H, Nakamura Y, Tsuya A, Shukuya T, Ono A, Akamatsu H, Watanabe R, Ono S, Mori K, Kanbara H, Yamaguchi K, Tanaka T, Matsunaga T, Yamamoto N. Hosokawa M, et al. Among authors: mori k. PLoS One. 2013 Jun 28;8(6):e67466. doi: 10.1371/journal.pone.0067466. Print 2013. PLoS One. 2013. PMID: 23840710 Free PMC article. Clinical Trial.
Comparison of the time-to-response between radiotherapy and epidermal growth factor receptor--tyrosine kinase inhibitors for advanced non-small cell lung cancer with EGFR mutation.
Imai H, Shukuya T, Takahashi T, Fujiwara S, Mori K, Ono A, Akamatsu H, Taira T, Kenmotsu H, Naito T, Kaira K, Murakami H, Harada H, Endo M, Nakajima T, Yamamoto N. Imai H, et al. Among authors: mori k. Anticancer Res. 2013 Aug;33(8):3279-84. Anticancer Res. 2013. PMID: 23898092
Individual-level data on the relationships of progression-free survival, post-progression survival, and tumor response with overall survival in patients with advanced non-squamous non-small cell lung cancer.
Imai H, Takahashi T, Mori K, Ono A, Akamatsu H, Shukuya T, Taira T, Kenmotsu H, Naito T, Murakami H, Endo M, Nakajima T, Yamamoto N. Imai H, et al. Among authors: mori k. Neoplasma. 2014;61(2):233-40. doi: 10.4149/neo_2014_030. Neoplasma. 2014. PMID: 24299320
Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy.
Akamatsu H, Mori K, Naito T, Imai H, Ono A, Shukuya T, Taira T, Kenmotsu H, Murakami H, Endo M, Harada H, Takahashi T, Yamamoto N. Akamatsu H, et al. Among authors: mori k. BMC Cancer. 2014 Jan 14;14:18. doi: 10.1186/1471-2407-14-18. BMC Cancer. 2014. PMID: 24422706 Free PMC article.
Efficacy and safety of platinum combination chemotherapy re-challenge for relapsed patients with non-small-cell lung cancer after postoperative adjuvant chemotherapy of cisplatin plus vinorelbine.
Imai H, Shukuya T, Yoshino R, Muraki K, Mori K, Ono A, Akamatsu H, Taira T, Kenmotsu H, Naito T, Murakami H, Tomizawa Y, Takahashi T, Takahashi K, Saito R, Yamamoto N. Imai H, et al. Among authors: mori k. Chemotherapy. 2013;59(4):307-13. doi: 10.1159/000356155. Epub 2014 Jan 24. Chemotherapy. 2013. PMID: 24480845
Molecular profiling of small cell lung cancer in a Japanese cohort.
Wakuda K, Kenmotsu H, Serizawa M, Koh Y, Isaka M, Takahashi S, Ono A, Taira T, Naito T, Murakami H, Mori K, Endo M, Nakajima T, Ohde Y, Takahashi T, Yamamoto N. Wakuda K, et al. Among authors: mori k. Lung Cancer. 2014 May;84(2):139-44. doi: 10.1016/j.lungcan.2014.02.013. Epub 2014 Mar 3. Lung Cancer. 2014. PMID: 24657128
Assessment of mutational profile of Japanese lung adenocarcinoma patients by multitarget assays: a prospective, single-institute study.
Serizawa M, Koh Y, Kenmotsu H, Isaka M, Murakami H, Akamatsu H, Mori K, Abe M, Hayashi I, Taira T, Maniwa T, Takahashi T, Endo M, Nakajima T, Ohde Y, Yamamoto N. Serizawa M, et al. Among authors: mori k. Cancer. 2014 May 15;120(10):1471-81. doi: 10.1002/cncr.28604. Epub 2014 Apr 3. Cancer. 2014. PMID: 24700479 Free article.
7,395 results